Skip to content

    Recently Viewed

      Listening...

      Home / Latest news /
      8 things to know about Johnson & Johnson’s Janssen COVID-19 Vaccine
      Johnson & Johnson employee preparing vials of the COVID-19 vaccine

      8 things to know about Johnson & Johnson’s Janssen COVID-19 Vaccine

      As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.

      Share Article
      share to
      CovidIG030921

      More from Johnson & Johnson

      Innovation
      IL-23 protein structures

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      Innovation
      Four 3D DNA structures illustration

      What is a gene mutation?

      Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. For DNA Day learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.
      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.